Sartorius Stedim Biotech

OverviewSuggest Edit

Sartorius Stedim Biotech is a provider of products and services for the development, quality assurance and production processes of the biopharmaceutical industry. The Company's integrated solutions include fermentation, filtration, purification, fluid management, cell culture media, and lab technologies that support the biopharmaceutical industry to develop and produce drugs.

TypePublic
Founded1870
HQAubagne, FR
Employee Ratings3.6

Latest Updates

Employees (est.) (Feb 2019)5,100(-3%)
Share Price (Nov 2020)€304.8

Key People/Management at Sartorius Stedim Biotech

Joachim Kreuzburg

Joachim Kreuzburg

Chairman of the Executive Board | CEO
Daniela Favoccia

Daniela Favoccia

Board Member
Rainer Lehmann

Rainer Lehmann

Member of the Executive Board | CFO
Ilke Hildegard Panzer

Ilke Hildegard Panzer

Board Member
Show more

Sartorius Stedim Biotech Office Locations

Sartorius Stedim Biotech has offices in Aubagne and Bohemia
Aubagne, FR (HQ)
Avenue de Jouques, ZI des Paluds
Bohemia, US
5 Orville Drive
Show all (2)

Sartorius Stedim Biotech Financials and Metrics

Sartorius Stedim Biotech Revenue

Market capitalization (19-Nov-2020)

28.1b

Closing stock price (19-Nov-2020)

304.8
Sartorius Stedim Biotech's current market capitalization is €28.1 b.
Show all financial metrics

Sartorius Stedim Biotech Online and Social Media Presence

Embed Graph

Sartorius Stedim Biotech News and Updates

Sartorius Stedim Biotech With Dynamic Growth in the First Half; 2020 Revenue and Earnings Forecast Raised

AUBAGNE, France, July 21, 2020 /PRNewswire/ -- Based on dynamic business performance in the first six months of 2020 and on expectations that demand will remain high for the rest of the year, Sartorius Stedim Biotech, a leading partner of the biopharma industry, raised its growth and...

Resolutions of the Annual Shareholders' Meeting of Sartorius Stedim Biotech S.A.

AUBAGNE, France, June 24, 2020 /PRNewswire/ -- At the virtual combined Annual General Shareholders' Meeting (ASM) of Sartorius Stedim Biotech S.A., shareholders passed the resolution to pay a dividend of €0.34 per share for fiscal 2019. The previous year's dividend was €0.57 per share....

Sartorius Stedim Biotech Confirms Preliminary Figures; Strong Outlook for 2020

AUBAGNE, France, Feb. 18, 2020 /PRNewswire/ -- Group sales revenue up 17.0% in constant currencies; underlying EBITDA margin(1) up 1.1 percentage point to 29.3% Dividend proposal of 0.68 euros per share Positive outlook for 2020: Sales revenue expected to rise 11% to 14% in constant...

Sartorius Stedim Biotech Group Grows by Double Digits in 2019; Strong Outlook for 2020

AUBAGNE, France, Jan. 28, 2020 /PRNewswire/ -- Sartorius Stedim Biotech (SSB), a leading partner of the biopharma industry, has continued on its profitable growth track in fiscal 2019. According to preliminary figures, the Group grew by double digits in sales revenue, order intake and...

Global $7 Bn Single-use Bioprocessing Market 2019-2024: Major Vendors are Thermo Fisher Scientific, Sartorius Stedim Biotech, Merck, Danaher, GE Healthcare & Avantor

DUBLIN, Nov 27, 2018 /PRNewswire/ -- The "Single-use Bioprocessing Market - Global Outlook and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering. The global single-use bioprocessing market is anticipated to reach revenues of approximately $7 billion by 2024,...

Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors

GÖTTINGEN, Germany and WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Sartorius Stedim Biotech (SSB) (Euronext: DIM), a leading international supplier for the biopharmaceutical industry, and Repligen Corporation (NASDAQ:RGEN), a global life sciences company focused on bioprocessing technologie…

Sartorius Stedim Biotech Frequently Asked Questions

  • When was Sartorius Stedim Biotech founded?

    Sartorius Stedim Biotech was founded in 1870.

  • Who are Sartorius Stedim Biotech key executives?

    Sartorius Stedim Biotech's key executives are Joachim Kreuzburg, Daniela Favoccia and Rainer Lehmann.

  • How many employees does Sartorius Stedim Biotech have?

    Sartorius Stedim Biotech has 5,100 employees.

  • Who are Sartorius Stedim Biotech competitors?

    Competitors of Sartorius Stedim Biotech include Nevzat Pharmaceutical Wholesale, aspUraclip and DCC Vital.

  • Where is Sartorius Stedim Biotech headquarters?

    Sartorius Stedim Biotech headquarters is located at Avenue de Jouques, ZI des Paluds, Aubagne.

  • Where are Sartorius Stedim Biotech offices?

    Sartorius Stedim Biotech has offices in Aubagne and Bohemia.

  • How many offices does Sartorius Stedim Biotech have?

    Sartorius Stedim Biotech has 2 offices.